Squarepoint’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$58.4M Sell
120,900
-119,300
-50% -$31.7M 0.06% 289
2026
Q1
$26.3M Sell
240,200
-77,100
-24% -$11M 0.03% 569
2025
Q4
$52.8M Buy
317,300
+183,500
+137% +$30.7M 0.06% 387
2025
Q3
$26.2M Buy
133,800
+124,400
+1,323% +$20.5M 0.03% 622
2025
Q2
$850K Sell
9,400
-140,400
-94% -$11.1M ﹤0.01% 2809
2025
Q1
$8.94M Buy
149,800
+132,900
+786% +$12.3M 0.01% 1083
2024
Q4
$2.24M Buy
+16,900
New +$1.59M ﹤0.01% 2314

Other funds holding ALAB

Squarepoint's ALAB Position: Q2 2026 in Review

Squarepoint increased its Astera Labs (ALAB) stake by 124% in Q2 2026, buying an estimated $46.6M and bringing the position to 317,208 shares worth $153M. The position accounts for 0.17% of the portfolio, ranked #102.

Squarepoint first reported a position in ALAB in Q1 2024 and has held it in 10 quarters since. 989 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Squarepoint held 317,208 shares of Astera Labs worth $153M as of Q2 2026.
  • Squarepoint bought 175,651 Astera Labs shares in Q2 2026, an estimated $46.6M.
  • Astera Labs made up 0.17% of Squarepoint's portfolio in Q2 2026, its #102 holding.
  • Squarepoint first reported a position in Astera Labs in Q1 2024 and has held it in 10 quarters since.
  • 989 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.